The Food and Drug Administration (FDA) said on Wednesday, Feb. 9 that the coronavirus disease (COVID-19) pill Molnupiravir of Lloyd Laboratories Inc. may be marketed by the firm at P50 to P75 per capsule. Molnupiravir (AFP / MANILA BULLETIN) During a Laging Handa press briefing,...